Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Tashkin

Chest

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Chest|February 1, 1977
Therapeutic advantages of the newer bronchodilator compoundsD P Tashkin
Chest|February 23, 1999
Extra-fine corticosteroid aerosols from hydrofluoroalkane-134a metered-dose inhalers: potential advantages and disadvantagesD P Tashkin
Chest|October 1, 1995
What is the true impact of crack on the lung?D P Tashkin
Chest|May 1, 1995
Multiple dose regimens. Impact on complianceD P Tashkin
Chest|July 1, 1985
Is the MVV:FEV1 ratio useful for assessing spirometry validity?P Harber, K SooHoo, D P Tashkin
Chest|April 1, 1977
Tetrahydrocannabinol as a bronchodilator. Why botherB J Shapiro, D P Tashkin, L Vachon
Chest|August 1, 1981
Alcohol-induced bronchospasm in an asthmatic patient: pharmacologic evaluation of the mechanismH Gong, D P Tashkin, B M Calvarese
Chest|September 1, 1987
Physiologic categorization of asbestos-exposed workersP Harber, D P Tashkin, M Lew, et al.
Chest|June 16, 2001
Gender bias in the diagnosis of COPDK R Chapman, D P Tashkin, D J Pye
Chest|March 1, 1994
Factitious hemoptysis. Adding to the differential diagnosisJ B Baktari, D P Tashkin, G W Small
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Chest|February 1, 1977
Therapeutic advantages of the newer bronchodilator compoundsD P Tashkin
Chest|February 23, 1999
Extra-fine corticosteroid aerosols from hydrofluoroalkane-134a metered-dose inhalers: potential advantages and disadvantagesD P Tashkin
Chest|October 1, 1995
What is the true impact of crack on the lung?D P Tashkin
Chest|May 1, 1995
Multiple dose regimens. Impact on complianceD P Tashkin
Chest|July 1, 1985
Is the MVV:FEV1 ratio useful for assessing spirometry validity?P Harber, K SooHoo, D P Tashkin
Chest|April 1, 1977
Tetrahydrocannabinol as a bronchodilator. Why botherB J Shapiro, D P Tashkin, L Vachon
Chest|August 1, 1981
Alcohol-induced bronchospasm in an asthmatic patient: pharmacologic evaluation of the mechanismH Gong, D P Tashkin, B M Calvarese
Chest|September 1, 1987
Physiologic categorization of asbestos-exposed workersP Harber, D P Tashkin, M Lew, et al.
Chest|June 16, 2001
Gender bias in the diagnosis of COPDK R Chapman, D P Tashkin, D J Pye
Chest|March 1, 1994
Factitious hemoptysis. Adding to the differential diagnosisJ B Baktari, D P Tashkin, G W Small
Pageof 5